Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Follow-up of SARS-CoV-2 (COVID-19) Immunity in Immunocompromised Populations in Belgium (COVICO) in Nursing Home Residents and Staff During the Winter Season 2022-2023

NCT05667597 is registered in ClinicalTrials.gov with Maria Goossens as lead sponsor.

NCT NCT05667597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05667597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Follow-up of SARS-CoV-2 (COVID-19) Immunity in Immunocompromised Populations in Belgium (COVICO) in Nursing Home Residents and Staff During the Winter Season 2022-2023
Lead sponsor
Maria Goossens
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 23, 2023
Completion date
December 31, 2026
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars cov 2 infection